Perioperative Bleeding

Also known as: Peri-operative bleeding / Perioperative hemorrhage / Perioperative Blood Loss / Perioperative hemorrhage (disorder)

DrugDrug NameDrug Description
DB13884Albutrepenonacog alfaA recombinant Factor IX fused to recombinant human albumin used to treat hemophilia B.
DB09329Antihemophilic factor (recombinant), PEGylatedFor the management of hemophilia A (congenital factor VIII deficiency) [FDA label], . This medication is a human antihemophilic factor indicated in adolescent and adult patients (12 years and older)...
DB00025Antihemophilic factor, human recombinantA form of recombinant coagulation Factor VIII used to treat hemophilia A, von Willebrand disease, and Factor XIII deficiency.
DB16662Efanesoctocog alfaA recombinant DNA-derived, Factor VIII concentrate indicated for routine prophylaxis, on-demand treatment and control of bleeding episodes, and perioperative management of bleeding in patients with hemophilia A.
DB11607Efmoroctocog alfaA recombinant Factor VIII used to treat and prevent bleeding in hemophilia A.
DB12909Factor XIII (human)A purified form of Factor XIII that is used to prevent and treat surgical bleeding in patients with a Factor XIII deficiency.
DB13133Von Willebrand factor humanA blood clotting factor used to manage bleeding episodes in von Willebrand disease and hemophilia A.
DrugDrug NameTargetType
DB13884Albutrepenonacog alfaCoagulation factor Xtarget
DB13884Albutrepenonacog alfaCoagulation factor VIIIenzyme
DB09329Antihemophilic factor (recombinant), PEGylatedvon Willebrand factortarget
DB09329Antihemophilic factor (recombinant), PEGylatedvon Willebrand factorcarrier
DB00025Antihemophilic factor, human recombinantCoagulation factor Xtarget
DB00025Antihemophilic factor, human recombinantPhytanoyl-CoA dioxygenase, peroxisomaltarget
DB00025Antihemophilic factor, human recombinantCoagulation factor IXtarget
DB00025Antihemophilic factor, human recombinantAsialoglycoprotein receptor 2target
DB00025Antihemophilic factor, human recombinant78 kDa glucose-regulated proteintarget
DB00025Antihemophilic factor, human recombinantCalreticulintarget
DB00025Antihemophilic factor, human recombinantCalnexintarget
DB00025Antihemophilic factor, human recombinantProtein ERGIC-53target
DB00025Antihemophilic factor, human recombinantProlow-density lipoprotein receptor-related protein 1target
DB00025Antihemophilic factor, human recombinantMultiple coagulation factor deficiency protein 2target
DB00025Antihemophilic factor, human recombinantvon Willebrand factortarget
DB00025Antihemophilic factor, human recombinantProthrombinenzyme
DB00025Antihemophilic factor, human recombinantVitamin K-dependent protein Cenzyme
DB16662Efanesoctocog alfaLow-density lipoprotein receptor-related protein 2target
DB16662Efanesoctocog alfaBasement membrane-specific heparan sulfate proteoglycan core proteintarget
DB16662Efanesoctocog alfaCoagulation factor IXtarget
DB16662Efanesoctocog alfaCoagulation factor Xtarget
DB11607Efmoroctocog alfavon Willebrand factortarget
DB13133Von Willebrand factor humanCoagulation factor VIIItarget
DB13133Von Willebrand factor humanCollagen alpha-1(I) chaintarget
DB13133Von Willebrand factor humanA disintegrin and metalloproteinase with thrombospondin motifs 13enzyme
DB13133Von Willebrand factor humanAsialoglycoprotein receptor 1target
DB13133Von Willebrand factor humanProlow-density lipoprotein receptor-related protein 1target
DrugDrug NamePhaseStatusCount
DB00586Diclofenac3Completed1
DB01628Etoricoxib3Completed1
DB01098Rosuvastatin3Completed1
DB00302Tranexamic acid3Completed2